AZT inhibits HIV-1 replication in monocytes. 1988

M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon

UI MeSH Term Description Entries
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon
January 2005, Pathobiology : journal of immunopathology, molecular and cellular biology,
M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon
May 1997, The American journal of physiology,
M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon
June 1990, Journal of leukocyte biology,
M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon
April 2010, Retrovirology,
M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon
October 1994, AIDS (London, England),
M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon
November 2018, PLoS pathogens,
M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon
March 2004, The journal of gene medicine,
M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon
February 1995, International journal of clinical pharmacology and therapeutics,
M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon
February 1998, Clinical and experimental immunology,
M A Skinner, and T J Matthews, and T K Greenwall, and D P Bolognesi, and M Hebdon
January 2017, PloS one,
Copied contents to your clipboard!